VolitionRx Limited Schedules Third Quarter 2024 Earnings Conference Call and Business Update

Core Points - VolitionRx Limited will host a conference call on November 15, 2024, at 8:30 a.m. U.S. Eastern Time to discuss its Q3 2024 financial and operating results, along with a business update [1][2]. Company Overview - Volition is a multi-national company focused on advancing the science of epigenetics, aiming to save lives and improve outcomes for people and animals with life-altering diseases through earlier detection and monitoring [4]. - The company is developing and commercializing cost-effective blood tests for diagnosing and monitoring various diseases, including certain cancers and conditions associated with NETosis, such as sepsis [5]. Research and Development - Volition's R&D activities are primarily based in Belgium, with additional innovation laboratories and offices located in the U.S., London, and Singapore [6].